Symbol="TVTX"
AssetType="Common Stock"
Name="Travere Therapeutics Inc"
Description="Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California."
CIK="1438533"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="777 THIRD AVENUE 22ND FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1254159000"
EBITDA="-239268000"
PERatio="None"
PEGRatio="None"
BookValue="2.536"
DividendPerShare="0"
DividendYield="0"
EPS="-4.37"
RevenuePerShareTTM="3.392"
ProfitMargin="-1.31"
OperatingMarginTTM="-1.246"
ReturnOnAssetsTTM="-0.21"
ReturnOnEquityTTM="-1.454"
RevenueTTM="220524000"
GrossProfitTTM="-31354000"
DilutedEPSTTM="-4.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.175"
AnalystTargetPrice="28"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.56"
PriceToBookRatio="11.94"
EVToRevenue="5.17"
EVToEBITDA="-4.999"
Beta="0.403"
num_52WeekHigh="29.14"
num_52WeekLow="14.51"
num_50DayMovingAverage="16.47"
num_200DayMovingAverage="19.61"
SharesOutstanding="74608000"
DividendDate="None"
ExDividendDate="None"
symbol="TVTX"
open="17.06"
high="17.23"
low="16.50"
price="16.72"
volume="739794.00"
latest_trading_day="2023-08-01"
previous_close="17.19"
change="-0.47"
change_percent="-2.7341%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="2"
Volume_recent_avg="1241090"
Change_recent_avg="-0.01"
Delta_recent_avg="0.85"
Variance_recent_avg="0.43"
Change_ratio_recent_avg="-0.12"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="92"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="681"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0027.jpeg"
image_positive_thumbnail_id_2="690"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0018.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
